0000000001056661

AUTHOR

R. Marino

showing 10 related works from this author

R. Marino, N. Tzankova Dintcheva, F.P. La Mantia LLDPE/caly/compatibilizers nanocomposites: rheological behaviour under shear and non-isothermal elon…

2007

researchProduct

An Italian experience on crash modeling for roundabouts

2015

In the last few years a considerable amount of safety models and evaluation tasks have been developed and specifically dedicated to roundabouts. Several safety performance functions (SPFs), indeed, have been implemented for roundabouts worldwide. Since SPFs are developed using crashes, traffic volume and other characteristics of a specific site (or geographical area), their direct transferability to other contexts different from those in which SPFs were calibrated is not always possible and, in any case, it must be done very carefully. A safety performance function cannot be used without a transferability evaluation for sites not included in the geographic area for which it was developed. S…

roundaboutstransferabilitySettore ICAR/04 - Strade Ferrovie Ed Aeroportisafety performance functions
researchProduct

La pianificazione stradale in Sicilia, prima dell’unità d’Italia

2008

researchProduct

Morphology modification of a polyethylene/clay nanocomposite samples under convergent flow

2009

The morphology of PE/CL nanocomposite samples subjected to convergent flows is studied. Elongational flow – the typical flow involved in spinning and film-blowing processing operations – significantly increases with the reduction of the capillary diameter. The values of the convergent extensional stress (calculated by Cogswell's formula) for the PE/CL systems, for all the adopted capillary geometries, are greater than the calculated values for pure polyethylene. The applied convergent flow, at the entrance of the capillary, is able to change the clay morphology and consequently the final material properties on the PE/CL system with limited affinity between the matrix and organo-modified cla…

Morphology modificationconvergent flowmorphologypolyethylene/clay nanocompositefiber
researchProduct

Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study

2017

Objectives: Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of bisphosphonates (BP). Although the risk of ONJ increases with increasing duration of BP treatment, there are currently no reliable estimates of the ONJ time to onset (TTO). The objective of this study was to estimate the TTO and associated risk factors in BP-treated patients. Subjects and Methods: Retrospective analysis of data from 22 secondary care centres in seven countries relevant to 349 patients who developed BP-related ONJ between 2004 and 2012. Results: The median (95%CI) TTO was 6.0 years in patients treated with alendronate (n = 88) and 2.2 years in those treated with zoledronate (n = 218). Multiv…

MalebisphosphonateTime Factorsmedicine.medical_treatmentOsteoporosis0302 clinical medicineRisk Factors80 and overosteoporosijaw osteonecrosiAged 80 and overBone Density Conservation AgentsDiphosphonatesjaw osteonecrosisjaw osteonecrosis bisphosphonates breast cancer multiple myeloma prostate cance osteoporosisIncidenceIncidence (epidemiology)Otorhinolaryngology2734 Pathology and Forensic MedicineMiddle Agedprostate cancermultiple myeloma030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawFemaleAdultmedicine.medical_specialty2734Drug Administration SchedulePathology and Forensic Medicine03 medical and health sciencesbreast cancerbisphosphonates; breast cancer; jaw osteonecrosis; multiple myeloma; osteoporosis; prostate cancer; Adult; Aged; Aged 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cross-Sectional Studies; Diphosphonates; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Otorhinolaryngology; 2734; Pathology and Forensic Medicine; Dentistry (all)Internal medicinemedicineHumansBisphosphonates; Breast cancer; Jaw osteonecrosis; Multiple myeloma; Osteoporosis; Prostate cancer; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)prostate canceAdverse effectGeneral DentistrybisphosphonatesAgedProportional Hazards ModelsRetrospective StudiesBisphosphonate-associated osteonecrosis of the jawbusiness.industryProportional hazards modelRetrospective cohort study030206 dentistryBisphosphonatemedicine.diseaseosteoporosisSurgeryCross-Sectional StudiesOtorhinolaryngologyMultivariate AnalysisDentistry (all)businessOsteonecrosis of the jaw
researchProduct

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBi…

2020

Emicizumab has been approved in several countries for regular prophylaxis in patients with congenital haemophilia A and FVIII inhibitors because it substantially reduces their bleeding risk and improves quality of life. However, although significantly less frequent, some breakthrough bleeds may still occur while on emicizumab, requiring treatment with bypassing or other haemostatic agents. Thrombotic complications have been reported with the associated use of activated prothrombin complex concentrates. In addition, when surgery/invasive procedures are needed while on emicizumab, their management requires multidisciplinary competences and direct supervision by experts in the use of this agen…

Factor VIIIFVIII inhibitorSettore BIO/12Antibodies Bispecific Antibodies Monoclonal Humanized Factor VIII Hemophilia A Hemorrhage Hemostatics Humans Italy Quality of LifeFVIII inhibitorsHemorrhageAntibodies Monoclonal HumanizedHemophilia AAntibodiesHemostaticsbypassing agents; emergency; emicizumab; FVIII inhibitors; haemophilia AItalyhemic and lymphatic diseasesMonoclonalEmergencyHaemophilia AAntibodies BispecificQuality of LifeHumansBispecificBypassing agentsEmicizumabHumanizedBypassing agentHaemostasis
researchProduct

EFFETTO DI NANO-ARGILLE ORGANO-MODIFICATE E COMPATIBILIZZANTI SULLE PROPRIETA’ DI NANOCOMPOSITI A BASE DI LLDPE

2007

researchProduct

Improving Reliability of Road Safety Estimates with High Correlated Accidents Count Data

2007

researchProduct

Estimating traffic operations at multi-lane roundabouts: A case study

2014

This paper addresses traffic modeling issues at urban multi-lane roundabouts where, despite circulating vehicles have priority, negotiation of the right-of-way can occur between antagonist traffic flows, as a result of minor drivers’ failing to obey the nominal operating rule (stop or yield control). Existing models for the estimation of operational performances have the shortcoming of not representing the interdependencies between entering and circulating vehicles at multi-lane roundabouts. An analytical capacity model derived from field observations was developed for this kind of intersections in a previous study. The complexity of the model lies in the difficulty of observing the behavio…

traffic roundabout headway operational analysis performance estimates regression modelSettore ICAR/04 - Strade Ferrovie Ed Aeroporti
researchProduct

ROLE OF DORSAL RAPHE NUCLEUS AND VENTRAL TEGMENTAL AREA ON REWARD AND FEEDING BEHAVIORS IN MICE

Reward Feeding Dopamine Dorsal Raphe Nucleus Ventral Tegmental Area
researchProduct